What Is the Optimal NOAC for Korean NVAF Patients with Specific Considerations?
[Speaker] Jaemin Shim/Korea Univ.,Korea
Changing Paradigm in Anti-thrombotic Treatment in Patients with High Risk CAD and/or PAD
[Speaker] Jong-Young Lee/Sungkyunkwan Univ.,Korea